Effects of the trifunctional antibody catumaxomab (anti-EpCAM x anti-CD3) on proliferation and cytokine secretion of immune cells in malignant pleural effusion
Sebastian, M., Jaeger, M., Kiewe, P., Schuette, W., Wiewrodt, R., Lindhofer, H., Mueller, B., Friccius-Quecke, H., Friccius- Quecke, H., Schmittel, A.
Published in Journal of clinical oncology (20.06.2007)
Published in Journal of clinical oncology (20.06.2007)
Get full text
Journal Article
AB0299 REAL-WORLD ASSESSMENT OF GP2015 (ETANERCEPT BIOSIMILAR, SDZ-ETN): AN INTERIM ANALYSIS OF DATA FROM THE SELF-INJECTION ASSESSMENT QUESTIONNAIRE IN PATIENTS WITH RHEUMATOID ARTHRITIS IN THE COMPACT STUDY
Kellner, H., Askari, A., Kupka, T., Friccius-Quecke, H., Furlan, F., Hachaichi, S., Schmalzing, M.
Published in Annals of the rheumatic diseases (01.06.2020)
Published in Annals of the rheumatic diseases (01.06.2020)
Get full text
Journal Article
Role of three quantitatively dominant endogenous peptides from HLA-DRB10401 molecules in class II specific alloreactivity
Adibzadeh, M, Friccius, H, Bornhak, S, Max, H, Hambrecht, A, Sansom, D, Kalbacher, H, Schenk, A, Pohla, H, Pawelec, G
Published in Transplant immunology (01.12.1994)
Published in Transplant immunology (01.12.1994)
Get full text
Journal Article
The effects of the antifungal azoles itraconazole, fluconazole, ketoconazole and miconazole on cytokine gene expression in human lymphoid cells
Friccius, H, Pohla, H, Adibzadeh, M, Siegels-Hübenthal, P, Schenk, A, Pawelec, G
Published in International journal of immunopharmacology (01.07.1992)
Published in International journal of immunopharmacology (01.07.1992)
Get more information
Journal Article
5001 ORAL Intraperitoneal administration of the trifunctional antibody catumaxomab for treatment of malignant ascites due to ovarian carcinoma: Results of a phase II/III study
Parsons, S, Kutarska, E, Koralewski, P, Gore, M, Wimberger, P, Burges, A, Sroehlein, M.A, Friccius-Quecke, H, Jaeger, M, Heiss, M.M
Published in European journal of cancer supplements (2007)
Published in European journal of cancer supplements (2007)
Get full text
Journal Article
Phase II clinical trial to evaluate the safety of repeated cycles of intraperitoneal catumaxomab for the treatment of malignant ascites (SECIMAS)
Pietzner, K., Linke, R. G., Jäger, M., Lindhofer, H., Friccius-Quecke, H., Chen, F., Braicu, E. I., Oskay-Özcelik, G., Sehouli, J.
Published in Journal of clinical oncology (20.05.2010)
Published in Journal of clinical oncology (20.05.2010)
Get full text
Journal Article
Safety of catumaxomab: Cytokine-release-related symptoms as a possible predictive factor for efficacy in a pivotal phase II/III trial in malignant ascites
Bokemeyer, C., Heiss, M., Gamperl, H., Linke, R., Schulze, E., Friccius-Quecke, H., Lindhofer, H., Parsons, S.
Published in Journal of clinical oncology (20.05.2009)
Published in Journal of clinical oncology (20.05.2009)
Get full text
Journal Article
Treatment of non-small cell lung cancer (NSCLC) patients with the trifunctional antibody catumaxomab (anti-EpCAM x anti-CD3): Results of a phase I/II study
Passlick, B., Schmittel, A., Friccius-Quecke, H., Kanniess, F., Wiewrodt, R., Lindhofer, H., Jaeger, M., Sebastian, M.
Published in Journal of clinical oncology (20.06.2006)
Published in Journal of clinical oncology (20.06.2006)
Get full text
Journal Article
Interleukin 10 is a human T cell growth factor in vitro
Pawelec, Graham, Pohla, Heike, Schlotz, Elke, Rehbein, Arnika, Schaudt, Kurt, Hambrecht, Andreas, Friccius, Hilke
Published in Cytokine (Philadelphia, Pa.) (01.05.1995)
Published in Cytokine (Philadelphia, Pa.) (01.05.1995)
Get full text
Journal Article
The role of endogenous peptides in the direct pathway of alloreactivity to human MHC class II molecules expressed on CHO cells
Pawelec, G, Adibzadeh, M, Bornhak, S, Friccius, H, Halder, T, Kalbacher, H, Li, K, Max, H, Müller, C, Sansom, D, Thiel, F, Zeuthen, J
Published in Immunological reviews (01.12.1996)
Published in Immunological reviews (01.12.1996)
Get more information
Journal Article
Treatment of malignant pleural effusion with the trifunctional antibody catumaxomab (anti-EpCAM x anti-CD3): Results of a phase I/II study
Sebastian, M., Schuette, W., Schneller, F., Nilius, G., Lodziewski, S., Passlick, B., Hoffken, G., Friccius-Quecke, H., Jaeger, M., Schmittel, A.
Published in Journal of clinical oncology (20.06.2006)
Published in Journal of clinical oncology (20.06.2006)
Get full text
Journal Article
P-974 Treatment of non-small cell lung cancer (NSCLC) patients withthe trifunctional bispecific antibody catumaxomab (removab®) (anti-EpCAM × anti-CD3: Results of a phase I study
Sebastian, M., Schmittel, A., Friccius-Quecke, H., Kanniess, F., Wiewrodt, R., Lindhoter, H., Jaeger, M., Passlick, B.
Published in Lung cancer (Amsterdam, Netherlands) (01.07.2005)
Published in Lung cancer (Amsterdam, Netherlands) (01.07.2005)
Get full text
Journal Article
Human gamma delta T cells are resistant to induction of anergy but not to induction of cell death in vitro
Pawelec, G, Friccius, H, Boshell, M, Siegels-Hübenthal, P, Rehbein, A, Schlotz, E, Pohla, H, Schaudt, K, Sansom, D
Published in Cellular immunology (15.04.1995)
Published in Cellular immunology (15.04.1995)
Get full text
Journal Article
Role of three quantitatively dominant endogenous peptides from HLA-DRB1 ∗0401 molecules in class II specific alloreactivity
Adibzadeh, M., Friccius, H., Bornhak, S., Max, H., Hambrecht, A., Sansom, D., Kalbacher, H., Schenk, A., Pohla, H., Pawelec, G.
Published in Transplant immunology (01.12.1994)
Published in Transplant immunology (01.12.1994)
Get full text
Journal Article
Requirements for Stimulation or Anergy Induction in Alloreactive Human T Cell Clones
Pawelec, Graham, Kalbacher, Hubert, Pohla, Heike, Boshell, Martina, Max, Heiner, Friccius, Hilke, Adibzadeh, Medi, Hambrecht, Andreas, Sansom, David
Published in Cellular immunology (01.10.1994)
Published in Cellular immunology (01.10.1994)
Get full text
Journal Article